{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:11:01Z","timestamp":1767147061823,"version":"build-2238731810"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.gyobfe.2014.01.024","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T03:45:21Z","timestamp":1393386321000},"page":"174-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risques cardiovasculaires de la contraception orale estro-progestative\u00a0: au-del\u00e0 de la pol\u00e9mique\u2026"],"prefix":"10.1016","volume":"42","author":[{"given":"H.","family":"Gronier-Gouvernel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Robin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9837","key":"10.1016\/j.gyobfe.2014.01.024_bib0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0140-6736(12)60478-4","article-title":"Maternal deaths averted by contraceptive use: an analysis of 172\u00a0countries","volume":"380","author":"Ahmed","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gyobfe.2014.01.024_bib0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.beem.2012.09.004","article-title":"Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills","volume":"27","author":"Sitruk-Ware","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"8990","key":"10.1016\/j.gyobfe.2014.01.024_bib0015","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gyobfe.2014.01.024_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-7824(94)90106-6","article-title":"New progestogens in oral contraception","volume":"49","author":"Fotherby","year":"1994","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.gyobfe.2014.01.024_bib0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jfprhc-2011-100260","article-title":"Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets","volume":"38","author":"Dinger","year":"2012","journal-title":"J Fam Plan Reprod Health Care"},{"issue":"2","key":"10.1016\/j.gyobfe.2014.01.024_bib0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/jfprhc-2012-100577","article-title":"Combined hormonal contraceptives and the risk of venous and arterial thromboembolism and cardiovascular death: misuse of automated databases","volume":"39","author":"Shapiro","year":"2013","journal-title":"J Fam Plan Reprod Health Care"},{"issue":"2\u00a0Pt. 1","key":"10.1016\/j.gyobfe.2014.01.024_bib0035","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/AOG.0b013e3182994c43","article-title":"Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis","volume":"122","author":"Peragallo Urrutia","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"24","key":"10.1016\/j.gyobfe.2014.01.024_bib0040","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.gyobfe.2014.01.024_bib0045","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1093\/humrep\/17.9.2307","article-title":"Myocardial infarction and third generation oral contraceptives: aggregation of recent studies","volume":"17","author":"Spitzer","year":"2002","journal-title":"Hum Reprod Oxf Engl"},{"issue":"1","key":"10.1016\/j.gyobfe.2014.01.024_bib0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.beem.2012.11.003","article-title":"Hormonal contraceptives and arterial disease: an epidemiological update","volume":"27","author":"Plu-Bureau","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.gyobfe.2014.01.024_bib0055","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jacc.2008.09.042","article-title":"Contraceptive hormone use and cardiovascular disease","volume":"53","author":"Shufelt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.gyobfe.2014.01.024_bib0060","article-title":"Contraception orale et risque vasculaire","author":"Bouchard","year":"2013","journal-title":"Acad Nat Med"},{"issue":"5","key":"10.1016\/j.gyobfe.2014.01.024_bib0065","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ando.2012.09.001","article-title":"Hormonal contraception in women at risk of vascular and metabolic disorders: guidelines of the French Society of Endocrinology","volume":"73","author":"Gourdy","year":"2012","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.gyobfe.2014.01.024_bib0070","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"Van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.gyobfe.2014.01.024_bib0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.beem.2012.11.002","article-title":"Hormonal contraceptives and venous thromboembolism: an epidemiological update","volume":"27","author":"Plu-Bureau","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.gyobfe.2014.01.024_bib0080","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.gyobfe.2014.01.024_bib0085","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.gyobfe.2014.01.024_bib0090","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1586\/erc.09.175","article-title":"Venous thromboembolism in women taking hormonal contraceptives","volume":"8","author":"Blanco-Molina","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"4","key":"10.1016\/j.gyobfe.2014.01.024_bib0095","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jgyn.2013.03.015","article-title":"[DVT and combined oral contraceptives: update of the pluridisciplinary CNGOF-FNCGM-GEHT-SFMV group]","volume":"42","author":"Chabbert-Buffet","year":"2013","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.gyobfe.2014.01.024_bib0100","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20132009","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"issue":"8990","key":"10.1016\/j.gyobfe.2014.01.024_bib0105","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(95)91921-X","article-title":"Third-generation oral contraceptives: how risky\u00a0?","volume":"346","author":"Weiss","year":"1995","journal-title":"Lancet"},{"issue":"8990","key":"10.1016\/j.gyobfe.2014.01.024_bib0110","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study, World Health Organization collaborative study of cardiovascular disease and steroid hormone, contraception","volume":"346","year":"1995","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.gyobfe.2014.01.024_bib0115","first-page":"482","article-title":"Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?","volume":"81","author":"Odlind","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6","key":"10.1016\/j.gyobfe.2014.01.024_bib0120","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1538-7836.2012.04720.x","article-title":"Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives","volume":"10","author":"Raps","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.gyobfe.2014.01.024_bib0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0037-1613960","article-title":"A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways","volume":"84","author":"Tans","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.gyobfe.2014.01.024_bib0130","article-title":"Risk of venous thrombosis in users of hormonal contraceptives in German gynaecological practices: a patient database analysis","author":"Ziller","year":"2013","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.gyobfe.2014.01.024_bib0135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/09513590701214414","article-title":"Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line","volume":"23","author":"Paris","year":"2007","journal-title":"Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol"},{"key":"10.1016\/j.gyobfe.2014.01.024_bib0140","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1136\/bmj.d2139","article-title":"Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database","volume":"342","author":"Parkin","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.gyobfe.2014.01.024_bib0145","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1136\/bmj.d2151","article-title":"Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data","volume":"342","author":"Jick","year":"2011","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.gyobfe.2014.01.024_bib0150","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/1471-0528.12210","article-title":"Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review","volume":"120","author":"Wu","year":"2013","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.gyobfe.2014.01.024_bib0155","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475\u00a0women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.gyobfe.2014.01.024_bib0160","first-page":"191","article-title":"Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis","volume":"35","author":"Manzoli","year":"2012","journal-title":"Drug Saf Int J Med Toxicol Drug Exp"},{"issue":"4","key":"10.1016\/j.gyobfe.2014.01.024_bib0165","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.contraception.2011.03.024","article-title":"The efficacy and safety of an oral contraceptive containing chlormadinone acetate: results of a pooled analysis of noninterventional trials in adult and adolescent women","volume":"84","author":"Schramm","year":"2011","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.gyobfe.2014.01.024_bib0170","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.thromres.2008.04.022","article-title":"Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: a cross-over study","volume":"123","author":"Fleischer","year":"2009","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.gyobfe.2014.01.024_bib0175","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1160\/TH10-05-0327","article-title":"Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate\/17\u03b2-estradiol, compared with those of levonorgestrel\/ethinyl estradiol. A double-blind, randomised study","volume":"105","author":"Gaussem","year":"2011","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.gyobfe.2014.01.024_bib0180","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/11591200-000000000-00000","article-title":"Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate\/dienogest versus ethinylestradiol\/levonorgestrel","volume":"11","author":"Klipping","year":"2011","journal-title":"Drugs R\u00a0D"},{"issue":"6","key":"10.1016\/j.gyobfe.2014.01.024_bib0185","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.contraception.2012.12.011","article-title":"Ethinyl estradiol and 17\u03b2-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment","volume":"87","author":"Stanczyk","year":"2013","journal-title":"Contraception"},{"issue":"8990","key":"10.1016\/j.gyobfe.2014.01.024_bib0190","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gyobfe.2014.01.024_bib0195","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1160\/TH04-11-0759","article-title":"Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The thrombosis: risk and economic assessment of thrombophilia screening (TREATS) study","volume":"94","author":"Wu","year":"2005","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.gyobfe.2014.01.024_bib0200","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jmv.2009.02.005","article-title":"Recommendations on testing for thrombophilia in venous thromboembolic disease: a French consensus guideline","volume":"34","author":"Pernod","year":"2009","journal-title":"J Mal Vasc"},{"issue":"4","key":"10.1016\/j.gyobfe.2014.01.024_bib0205","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.gyobfe.2008.02.006","article-title":"[Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?]","volume":"36","author":"Plu-Bureau","year":"2008","journal-title":"Gynecol Obstet Fertil"},{"issue":"4","key":"10.1016\/j.gyobfe.2014.01.024_bib0210","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13625180008500402","article-title":"The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives","volume":"5","author":"Nightingale","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"10.1016\/j.gyobfe.2014.01.024_bib0215","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1783\/0000000052972988","article-title":"Potential impact of oral contraceptive choice on myocardial infarction mortality and deep vein thrombosis","volume":"31","author":"Martin","year":"2005","journal-title":"J Fam Plan Reprod Health Care"},{"key":"10.1016\/j.gyobfe.2014.01.024_bib0220","first-page":"CD004425","article-title":"Combined oral contraceptive pills for treatment of acne","volume":"7","author":"Arowojolu","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.gyobfe.2014.01.024_bib0225","first-page":"CD003987","article-title":"Combination contraceptives: effects on weight","author":"Gallo","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.gyobfe.2014.01.024_bib0230","first-page":"CD006586","article-title":"Oral contraceptives containing drospirenone for premenstrual syndrome","author":"Lopez","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"9010","key":"10.1016\/j.gyobfe.2014.01.024_bib0235","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0140-6736(96)90775-8","article-title":"Pregnancy terminations after oral contraception scare","volume":"347","author":"Child","year":"1996","journal-title":"Lancet"},{"issue":"9113","key":"10.1016\/j.gyobfe.2014.01.024_bib0240","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(05)79443-5","article-title":"Pregnancies and terminations after 1995\u00a0warning about third-generation oral contraceptives","volume":"351","author":"Jick","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2014.01.024_bib0245","article-title":"\u00c9volution de l\u2019utilisation en France des contraceptifs oraux combin\u00e9s (COC) et autres contraceptifs de d\u00e9cembre 2012\u00a0\u00e0 aout 2013","year":"2013","journal-title":"ANSM"},{"issue":"2","key":"10.1016\/j.gyobfe.2014.01.024_bib0250","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jgyn.2011.09.033","article-title":"[Contraception news]","volume":"41","author":"Vincent-Rohfritsch","year":"2012","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.gyobfe.2014.01.024_bib0255","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1749-6632.2010.05688.x","article-title":"The future of women's contraception: stakes and modalities","volume":"1205","author":"Hugon-Rodin","year":"2010","journal-title":"Ann N Y Acad Sci"}],"updated-by":[{"DOI":"10.1016\/j.gyobfe.2014.03.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000}}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958914000460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958914000460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T20:08:02Z","timestamp":1565208482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297958914000460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1297958914000460"],"URL":"https:\/\/doi.org\/10.1016\/j.gyobfe.2014.01.024","relation":{},"ISSN":["1297-9589"],"issn-type":[{"value":"1297-9589","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risques cardiovasculaires de la contraception orale estro-progestative\u00a0: au-del\u00e0 de la pol\u00e9mique\u2026","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gyobfe.2014.01.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}